Prices are updated after-hours
Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2021 - 12 - 16    symbols : EBS    save search
Emergent BioSolutions Announces Initiation of Phase 1 Study Evaluating Its Universal Influenza Vaccine Candidate
Published: 2021-12-16 (Crawled : 13:30) - biospace.com/
EBS | News | $2.145 -6.33% 560K twitter stocktwits trandingview |
Health Technology
 | | O: 3.55% H: 2.32% C: 0.54%
phase 1 vaccine influenza merge phase 2 phase 3
Gainers vs Losers
58% 42%

Top 10 Gainers
CSSE 4 | $0.3831 151.54% 190M twitter stocktwits trandingview |
Consumer Services
CZOO | $11.04 121.24% 11M twitter stocktwits trandingview |

LICN | $0.9107 62.63% 14M twitter stocktwits trandingview |

BOF | $1.87 59.83% 100M twitter stocktwits trandingview |

AMST | $3.18 59.0% 67M twitter stocktwits trandingview |
Technology Services
SKIL 4 | $8.72 52.72% 410K twitter stocktwits trandingview |
Information
MTC | $3.31 47.77% 7.7M twitter stocktwits trandingview |
Technology Services
MULN | News | $3.915 43.41% 12M twitter stocktwits trandingview |
Information
WIMI | $1.04 43.37% 17M twitter stocktwits trandingview |
Technology Services
RILY | $29.755 36.99% 12M twitter stocktwits trandingview |
Finance
Your saved searches
Save your searches and get alerts when important news are released.